MDT vs SYK
Medtronic PLC and Stryker Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | MDT | SYK |
|---|---|---|
| Revenue | $36.4B | $25.1B |
| Net income | $4.8B | $3.2B |
| Gross margin | 65.0% | 64.0% |
| Net margin | 13.3% | 12.9% |
| Return on equity | 9.8% | 15.1% |
| Diluted EPS | $3.73 | $8.40 |
| Dividend / share | $2.84 | · |
| Payout ratio | 75.8% | 39.6% |
| Free cash flow | $5.4B | $4.3B |
| Equity | $49.5B | · |
| Net debt / equity | 0.53× | 0.53× |
| Current ratio | 2.13× | 1.89× |
| Revenue CAGR 5y | 3.8% | 11.8% |
| Profit CAGR 5y | 5.9% | 15.2% |
MDT bills 1.4× the revenue of SYK, and keeps more of each dollar of revenue as profit (13.3% against 12.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | MDT | SYK |
|---|---|---|
| FY2025 | $36.4B | $25.1B |
| FY2024 | $33.5B | $22.6B |
| FY2023 | $32.4B | $20.5B |
| FY2022 | $31.2B | $18.4B |
| FY2021 | $31.7B | $17.1B |
| FY2020 | $30.1B | $14.4B |
| FY2019 | $28.9B | $14.9B |
| FY2018 | $30.6B | $13.6B |
| FY2017 | $30.0B | $12.4B |
| FY2016 | $29.7B | $11.3B |
Bottom line
| Fiscal year | MDT | SYK |
|---|---|---|
| FY2025 | $4.8B | $3.2B |
| FY2024 | $4.7B | $3.0B |
| FY2023 | $3.7B | $3.2B |
| FY2022 | $3.8B | $2.4B |
| FY2021 | $5.0B | $2.0B |
| FY2020 | $3.6B | $1.6B |
| FY2019 | $4.8B | $2.1B |
| FY2018 | $4.6B | $3.6B |
| FY2017 | $3.1B | $1.0B |
| FY2016 | $4.0B | $1.6B |
14 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$11,248,000,000 | MDT |
| FY2024 | +$10,942,000,000 | MDT |
| FY2023 | +$11,866,000,000 | MDT |
| FY2022 | +$12,778,000,000 | MDT |
| FY2021 | +$14,578,000,000 | MDT |
| FY2020 | +$15,766,000,000 | MDT |
| FY2019 | +$14,029,000,000 | MDT |
| FY2018 | +$16,956,000,000 | MDT |
| FY2017 | +$17,509,000,000 | MDT |
| FY2016 | +$18,385,000,000 | MDT |
| FY2015 | +$18,887,000,000 | MDT |
| FY2014 | +$10,586,000,000 | MDT |
| FY2013 | +$7,984,000,000 | MDT |
| FY2012 | +$7,933,000,000 | MDT |
MDT has reported the higher revenue in every one of these 14 fiscal years. The gap has widened since the earliest year compared.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
14 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +0.4 pp | MDT |
| FY2024 | +0.7 pp | MDT |
| FY2023 | −4.0 pp | SYK |
| FY2022 | −0.7 pp | SYK |
| FY2021 | +4.3 pp | MDT |
| FY2020 | +0.9 pp | MDT |
| FY2019 | +2.6 pp | MDT |
| FY2018 | −10.9 pp | SYK |
| FY2017 | +2.1 pp | MDT |
| FY2016 | −1.0 pp | SYK |
| FY2015 | −2.2 pp | SYK |
| FY2014 | +7.9 pp | MDT |
| FY2013 | +6.9 pp | MDT |
| FY2012 | +5.9 pp | MDT |
The higher net margin has changed hands between MDT and SYK over this period.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
SYK's net margin has been more volatile than MDT's over the 14 comparable fiscal years — 4.5 percentage points of standard deviation against 2.8.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between MDT and SYK over these 14 fiscal years — MDT led in 9 and SYK in 5.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
SYK's return on equity has been more volatile than MDT's over the 14 comparable fiscal years — 5.7 percentage points of standard deviation against 3.5.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between MDT and SYK over these 14 fiscal years — MDT led in 3 and SYK in 11.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.